Prof. Moussa Seydi gave his opinion on the use of Chloroquine which is causing controversy worldwide today.
Prof. Moussa Seydi gave his opinion on the use of Chloroquine which is causing controversy worldwide today. But, revealing the results of his study, he assured that he would continue treatment on the basis of this molecule.
“In our research project, we were able to analyze the data of 559 patients. These data come from Fann, Dalal Jam and Diamniadio. 498 are over 12 years of age, the median age being 33 years. But, all ages were represented. From infants to subjects 85 years of age. There were as many men as women. One in five patients had comorbidity.
This treatment with hydroxichloroquine and azymetrocin that we administered showed us that the effectiveness was real. Because the median hospital stay for patients who took this treatment was 10.5 days compared to 13 days for patients who did not take this treatment.
All the patients who had taken this treatment before the onset of complications were cured and none died. Regarding tolerance, so far we have only found 12 side effects, or about 2% of the time. Cardiovascular side effects were seen in 0.8% of cases and all side effects were mild.
This means that treatment with azymetrocin and hydroxychloroquine is effective in reducing viral load because patients only go out after two negative viral loads. This treatment is effective in preventing complications that can lead to death if taken early and this treatment is well tolerated.
Given this controversy, we will only use our results to make decisions. We will therefore continue our treatment, continue to evaluate the treatments currently available in relation to the Pasteur Institute in Dakar. “